MERCURY LABORATORIES Financial Statement Analysis
|
||
The Revenues of MERCURY LABORATORIES have increased by 30.06% YoY .
The Earnings Per Share (EPS) of MERCURY LABORATORIES has increased by 56.64 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
MERCURY LABORATORIES Last 5 Annual Financial Results
[BOM: 538964]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹75 Cr | ₹58 Cr | ₹69 Cr | ₹57 Cr | ₹56 Cr |
Expenses | ₹67 Cr | ₹51 Cr | ₹59 Cr | ₹51 Cr | ₹50 Cr |
Operating Profit (Excl OI) | ₹8.57 Cr | ₹6.99 Cr | ₹9.59 Cr | ₹6.17 Cr | ₹5.72 Cr |
Other Income | ₹1.72 Cr | ₹0.82 Cr | ₹0.88 Cr | ₹0.85 Cr | ₹1.04 Cr |
Interest | ₹0.36 Cr | ₹0.45 Cr | ₹0.64 Cr | ₹0.82 Cr | ₹1.09 Cr |
Depreciation | ₹2.48 Cr | ₹2.45 Cr | ₹1.92 Cr | ₹1.87 Cr | ₹1.63 Cr |
Profit Before Tax | ₹7.49 Cr | ₹5.03 Cr | ₹7.91 Cr | ₹4.33 Cr | ₹4.05 Cr |
Profit After Tax | ₹5.58 Cr | ₹3.56 Cr | ₹5.34 Cr | ₹3.23 Cr | ₹2.84 Cr |
Consolidated Net Profit | ₹5.58 Cr | ₹3.56 Cr | ₹5.34 Cr | ₹3.23 Cr | ₹2.84 Cr |
Earnings Per Share (Rs) | ₹46.49 | ₹29.68 | ₹44.48 | ₹26.90 | ₹23.63 |
PAT Margin (%) | 7.41 | 6.15 | 7.78 | 5.64 | 5.11 |
ROE(%) | 12.98 | 9.23 | 15.50 | 10.59 | 10.26 |
ROCE(%) | 16.29 | 12.26 | 20.56 | 13.25 | 13.77 |
Total Debt/Equity(x) | 0.12 | 0.13 | 0.19 | 0.22 | 0.33 |
Key Financials |
||
Market Cap | : | ₹ 124.1 Cr |
Revenue (TTM) | : | ₹ 73.9 Cr |
Net Profit(TTM) | : | ₹ 5.0 Cr |
EPS (TTM) | : | ₹ 41.6 |
P/E (TTM) | : | 24.8 |
Industry Peers & Returns | 1W | 1M | 1Y |
MERCURY LABORATORIES | -5.4% | 6.4% | 25.9% |
SUN PHARMACEUTICAL INDUSTRIES | -0.4% | 4.7% | 60.2% |
CIPLA | -1.3% | 2.8% | 33.9% |
DR REDDYS LABORATORIES | -2.3% | -7.8% | 14.4% |
ZYDUS LIFESCIENCES | -5.7% | -12.6% | 68.7% |
DIVIS LABORATORIES | -1.1% | 11% | 43.2% |
MERCURY LABORATORIES Revenues
[BOM: 538964]
Y-o-Y | 30.06 % |
5 Yr CAGR | 7.93 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹75 Cr | 30.06 | |
Mar2022 | ₹58 Cr | -15.57 | |
Mar2021 | ₹69 Cr | 19.79 | |
Mar2020 | ₹57 Cr | 3.15 | |
Mar2019 | ₹56 Cr | - |
MERCURY LABORATORIES Operating Profit
[BOM: 538964]
Y-o-Y | 22.62 % |
5 Yr CAGR | 10.62 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹8.57 Cr | 22.62 | |
Mar2022 | ₹6.99 Cr | -27.12 | |
Mar2021 | ₹9.59 Cr | 55.55 | |
Mar2020 | ₹6.17 Cr | 7.74 | |
Mar2019 | ₹5.72 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -5.72 % |
5 Yr CAGR | 2.50 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 11.38% | -5.72 | |
Mar2022 | 12.07% | -13.66 | |
Mar2021 | 13.98% | 29.81 | |
Mar2020 | 10.77% | 4.46 | |
Mar2019 | 10.31% | - |
MERCURY LABORATORIES Profit After Tax
[BOM: 538964]
Y-o-Y | 56.63 % |
5 Yr CAGR | 18.43 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹5.58 Cr | 56.63 | |
Mar2022 | ₹3.56 Cr | -33.27 | |
Mar2021 | ₹5.34 Cr | 65.37 | |
Mar2020 | ₹3.23 Cr | 13.82 | |
Mar2019 | ₹2.84 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 20.49 % |
5 Yr CAGR | 9.74 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 7.41 % | 20.49 | |
Mar2022 | 6.15 % | -20.95 | |
Mar2021 | 7.78 % | 37.94 | |
Mar2020 | 5.64 % | 10.37 | |
Mar2019 | 5.11 % | - |
MERCURY LABORATORIES Earnings Per Share (EPS)
[BOM: 538964]
Y-o-Y | 56.64 % |
5 Yr CAGR | 18.43 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹46 | 56.64 | |
Mar2022 | ₹30 | -33.27 | |
Mar2021 | ₹44 | 65.35 | |
Mar2020 | ₹27 | 13.84 | |
Mar2019 | ₹24 | - |
MERCURY LABORATORIES Return on Capital Employed (ROCE)
[BOM: 538964]
Y-o-Y | 32.87 % |
5 Yr CAGR | 4.29 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 16.29% | 32.87 | |
Mar2022 | 12.26% | -40.37 | |
Mar2021 | 20.56% | 55.17 | |
Mar2020 | 13.25% | -3.78 | |
Mar2019 | 13.77% | - |
MERCURY LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹1,033.8 |
Current MarketCap | : | ₹ 124.1 Cr |
Updated EOD on | : | Sep 20,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -5.4% |
6.4% |
25.9% |
SENSEX | 0.3% |
3% |
23.3% |
MERCURY LABORATORIES related INDICES
You may also like the below Video Courses
FAQ about MERCURY LABORATORIES Financials
How the annual revenues of MERCURY LABORATORIES have changed ?
The Revenues of MERCURY LABORATORIES have increased by 30.06% YoY .
How the Earnings per Share (EPS) of MERCURY LABORATORIES have changed?
The Earnings Per Share (EPS) of MERCURY LABORATORIES has increased by 56.64 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs